Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 35
- Adult-Use
The four states who could legalize adult-use cannabis in 2023
WHO’S NEXT? The four states who could legalize adult-use cannabis in 2023 At least four states – Ohio, Oklahoma and Pennsylvania, in addition to Minnesota – have a good chance to legalize adult-use cannabis this year, writes MJ Biz Daily.
- Medical
Linnea SA Receives Swiss Narcotics License Allowing For The Production And Exportation Of High THC Active Pharmaceutical Ingredients
LINNEA SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics license by Swissmedic at the end of 2022.
- Companies
Kanabo Launches 2 New High-THC Vape Formulas As It Prepares To Compete On ‘Patient Care’ In 2023
KANABO announced the launch of two new additions to its range of VapePod formulas this week, in what is expected to be the first in a flurry of announcements due in the coming months.
- Adult-Use
U.S. Virgin Islands governor would be ‘foolish’ not to sign cannabis bill
LEGALIZATION BILL U.S. Virgin Islands governor would be ‘foolish’ not to sign cannabis bill The U.S.
- CBD Market
First cannabis bill heads to the new 118th Congress
FIRST OUT THE GATE First cannabis bill heads to the new 118th Congress Seeking Alpha reports that a group of GOP lawmakers in the U.S.
- Press releases
NHS Reimburses The Cost Of Cannabis Treatment To The First Zerenia Clinics UK Patient
PRESS RELEASE KHIRON Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), continues to spearhead the medical cannabis market in the United Kingdom by successfully attaining, for the first time, full reimbursement by the NHS of costs associated to cannabis-based medication and clinic fees for a patient enrolled in Zerenia™ Clinics UK.
- Companies
Celadon granted MHRA GMP certification for cannabis API
The UK-based pharmaceutical company has stated that the registration follows seven harvests and extractions and an MHRA inspection in 2022.
- Markets & Stocks
European Cannabis Stocks Review: Khiron Spikes On Colombian Insurance Deal, Apollon Divests Patents, & More From Seach Medical
Khiron Life Sciences INTERNATIONAL medical cannabis company Khiron has seen its share price skyrocket over 60% following a crucial resolution that was passed by the Colombian Ministry of Health.
- CBD Market
Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market
CANOPY GROWTH Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market The Motley Fool reports that Canopy’s sales in the second quarter of fiscal 2023 were reported as CAD$118 million, down 10% year over year.
- Companies
Apollon Formularies and Global Hemp Group sign Letter of Intent
UK-based Apollon Formularies and Global Hemp Group (GHG) have signed a Letter of Intent GHG will acquire the exclusive perpetual license for North America to certain Apollon Intellectual Property and proprietary technology.
- Medical
Italian Army Pledges To More Than Double Medical Cannabis Production This Year, But Supply Issues Far From Over
THE Italian army, which continues to hold a monopoly over medical cannabis production, has announced plans to dramatically ramp up production this year.
- Adult-Use
Arizona’s adult use sales are up as medical sales fall
NEW HIGHS Arizona’s adult use sales are up as medical sales fall Benzinga reports that Arizona’s adult-use cannabis sales reached a new high in October 2022, with more than USD$85.4 million in estimated sales, $5 million above the $80.4 million from September sales.
